cRCT of Long-acting PrEP Integrated with Community-based Sexual Health (LAPIS) – Clinical Management

South Africa, 2024 - 2026

Get Microdata

Reference ID

AHRI.LAPIS.ESource.Clinical.Management.2025.v1

Producer(s)

Prof. Maryam Shahmanesh, Dr. Limakatso Lebina

Collections

Multilevel HIV Prevention

Metadata

Documentation in PDF DDI/XML JSON

Created on

Feb 06, 2025

Last modified

Feb 06, 2025

Page views

9847

Downloads

Why is the participant switching their PrEP Treatment? - Increased HIV risk (pe (st_reas_switch_method_12)

Data file: AHRI.LAPIS.ESource.Clinical.Management.2025.v1

Overview

Valid: 0

Invalid: 3457

Type: Discrete

Decimal: 0

Width: 12

Range: 1 - 96

Format: Numeric

Questions and instructions

Categories

Value	Category
1	Experiencing short term side effects.
2	Worried about experiencing long term side effects.
3	Don't want to or finding it difficult to take a daily tablet.
4	Injection site issues e.g. pain
5	Challenges or Discomfort in inserting the vaginal ring
6	Finding it difficult to engage with PrEP services.
7	Challenges with the PrEP schedule for the particular PrEP modality
8	Partner/s or family member/s objected to me taking PrEP
9	Stigma (challenges from hiding the PrEP from family/partner/etc)
10	Inconvenience of the type of PrEP
11	Reduced HIV risk - e.g. don't have sex or Trust partner/s or knows their status.
12	Increased HIV risk (perceived or actual) - e.g. start having sex
13	Feel more confident with a different PrEP
14	Other prevention strategies are sufficient.
15	Want to try a different PrEP
16	Pregnancy
17	Prefer not to take PrEP as pregnant or trying to become.
96	Other reason
Sysmiss

Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.

Back to Catalog